| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/26/2004 | US20040039007 Nitrogen compounds such as (6-(3-Methylaminopropyl)-2-(2-tri-fluoromethylphenyl)pyrimidin-4-yl)-(1H -pyrazolo(3,4-b)pyridin-3-yl)-amine, use as glycogen synthase kinase-3 (GSK-3) antagonists |
| 02/26/2004 | US20040039006 (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 02/26/2004 | US20040039004 Nitrogen compounds such as 4-(5-amino-7-phenethyl-7H-pyrazolo (4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-2-yl)-phenol, used as adenosine receptor antagonists, for prophylaxis of nervous, cardiovascular, respiratory, urogenital and immune disorders |
| 02/26/2004 | US20040038999 6-alkoxy-pyrido-pyrimidines |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
| 02/26/2004 | US20040038978 Chemical compounds |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038974 Antiarthritic agents |
| 02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038964 Imidazole derivatives as raf kinase inhibitors |
| 02/26/2004 | US20040038963 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 02/26/2004 | US20040038961 Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/26/2004 | US20040038960 Treating arthritis |
| 02/26/2004 | US20040038958 Topical treatment of skin diseases |
| 02/26/2004 | US20040038954 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 02/26/2004 | US20040038951 Organic compounds |
| 02/26/2004 | US20040038943 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038929 Drugs against articular failure |
| 02/26/2004 | US20040038928 N-pyrazole A2A receptor agonists |
| 02/26/2004 | US20040038927 Methods of decreasing or preventing pain using spicamycin derivaties |
| 02/26/2004 | US20040038893 Prevention and reduction of blood loss |
| 02/26/2004 | US20040038887 Copolymers for suppression of autoimmune diseases, and methods of use |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040037876 Use or r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature |
| 02/26/2004 | US20040037875 Composition for treatment of inflammatory disorders |
| 02/26/2004 | US20040037872 Active substance-containing adhesive patch comprising diclofenac or a topically acceptable salt thereof; patch composed of outer impermeable backing layer, matrix layer comprising active substance, removable protective layer |
| 02/26/2004 | US20040037827 Administering antibody to integrin |
| 02/26/2004 | US20040037806 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/26/2004 | US20040037784 Particulate (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl) carbonyl)oxy)phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy) acetyl)amino)pentanoyl)amino) propanoic acid or a salt or solvate thereof and one or more suitable excipients for |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | CA2495452A1 Use of reboxetine for the treatment of hot flashes |
| 02/26/2004 | CA2495409A1 Diaryl compounds as monoamine reuptake inhibitors |
| 02/26/2004 | CA2494546A1 Substituted glycine derivatives for use as medicaments |
| 02/25/2004 | EP1391514A1 Pharmaceutical composition for treatment of angiogenesis-dependent conditions |
| 02/25/2004 | EP1391512A1 Polypeptide serving as angiogenic marker and dna thereof |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391452A1 4-hydroxpiperidine derivative with analgetic activity |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391211A1 Chondrogenesis promoters |
| 02/25/2004 | EP1391201A1 Medicinal compositions |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1391197A1 Process for preparation of compositions with a high content in avarol and their use |
| 02/25/2004 | EP1390740A1 Methods and formulations for increasing the affinity of a 1? adenosine receptor ligands for the a 1? adenosine receptor |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390478A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody |
| 02/25/2004 | EP1390474A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390383A1 Antisense permeation enhancers |
| 02/25/2004 | EP1390378A1 Pharmaceutically active uridine esters |
| 02/25/2004 | EP1390366A1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 02/25/2004 | EP1390365A1 Novel sulfonate substituted pyrazol pyridine dervivatives |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390362A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 02/25/2004 | EP1390361A2 Melanocortin receptor ligands |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390352A1 Pyrimidine derivatives |
| 02/25/2004 | EP1390351A1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390025A1 Coenzyme q and eicosapentaenoic acid (epa) |
| 02/25/2004 | EP1390023A2 Pharmaceutical salts |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1239878B1 Formulations of adenosine a1 agonists and 5ht1 agonists |
| 02/25/2004 | EP1232158B1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1087934B1 Aminocyclohexyl ether compounds and uses thereof |
| 02/25/2004 | EP0883405B1 Amidino protease inhibitors |
| 02/25/2004 | EP0873301B1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| 02/25/2004 | EP0790059B1 Means for treating auto-immune diseases |